SEC orders trading in Charming Medical securities be suspended

The SEC states in an order: “It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension in the trading of the securities of Charming Medical (MCTA) Limited, a holding company incorporated in the British Virgin Islands and headquartered in Hong Kong, because of potential manipulation in the securities of MCTA effectuated through recommendations made to investors by unknown persons via social media to purchase, hold, and/or sell the securities of MCTA and to send screenshots documenting their transaction, which appear to be designed to artificially inflate the price and trading volume of the securities of MCTA. As of November 10, 2025, the common stock of MCTA is listed on the Nasdaq Capital Market under the symbol “MCTA.” The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company.” It is ordered that trading in the securities is suspended for the period from 4:00 AM ET on November 12, 2025, through 11:59 PM ET on November 25, the SEC noted.